References
- Kipp M, Nyamoya S, Hochstrasser T, Amor S. Multiple sclerosis animal models: a clinical and histopathological perspective. Brain Pathol, 2017, 27(2):123-137. doi: 10.1111/bpa.12454.
- Seitaridou Y, Dimitrova M, Chamova T, et al. Cost-effectiveness of multiple sclerosis therapies – a literature review. Acta Medica Bulg, 2022, 49(4):69-80. doi: 10.2478/amb-2022-0046.
- Hauser SL, Aubert C, Burks JS, et al. Analysis of human T-lymphotrophic virus sequences in multiple sclerosis tissue. Nature, 1986, 322(6075):176-7. doi: 10.1038/322176a0.
- Matsushima GK, Morell P. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol, 2001, 11(1):107-16. doi: 10.1111/j.1750-3639.2001.tb00385.x.
- Ponta H, Sherman L, Herrlich PA. CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol, 2003, 4(1):33-45. doi: 10.1038/nrm1004.
- Teder P, Vandivier RW, Jiang D, et al. Resolution of lung inflammation by CD44. Science, 2002, 296(5565):155-8. doi: 10.1126/science.1069659.
- Dzwonek J, Wilczynski GM. CD44: molecular interactions, signaling and functions in the nervous system. Front Cell Neurosci, 2015, 9:175. doi: 10.3389/fncel.2015.00175.
- Geloso MC, Ria F, Corvino V, Di Sante G. Expression of CD44 and its spliced variants: innate and inducible roles in nervous tissue cells and their environment. Int J Mol Sci, 2025, 26(17):8223. doi: 10.3390/ijms26178223.
- Girgrah N, Letarte M, Becker LE, et al. Localization of the CD44 glycoprotein to fibrous astrocytes in normal white matter and to reactive astrocytes in active lesions in multiple sclerosis. J Neuropathol Exp Neurol, 1991, 50(6):779-92. doi: 10.1097/00005072-199111000-00009.
- Back SA, Tuohy TM, Chen H, et al. Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation. Nat Med, 2005, 11(9):966-72. doi: 10.1038/nm1279.
- Naruse M, Shibasaki K, Yokoyama S, et al. Dynamic changes of CD44 expression from progenitors to subpopulations of astrocytes and neurons in developing cerebellum. PLoS One. 2013;8(1):e53109. doi: 10.1371/journal.pone.0053109.
- Sawada R, Nakano-Doi A, Matsuyama T, et al. CD44 expression in stem cells and niche microglia/macrophages following ischemic stroke. Stem Cell Investig. 2020 Mar 10;7:4. doi: 10.21037/sci.2020.02.02.
- Reinbach C, Stadler MS, Pröbstl N, et al. CD44 expression in the cuprizone model. Brain Res, 2020, 1745:146950. doi: 10.1016/j.brainres.2020.146950.
- Flynn KM, Michaud M, Madri JA. CD44 deficiency contributes to enhanced experimental autoimmune encephalomyelitis: a role in immune cells and vascular cells of the blood-brain barrier. Am J Pathol. 2013 Apr;182(4):1322-36. doi: 10.1016/j.ajpath.2013.01.003.
- Landzhov B, Gaydarski L, Stanchev S, et al. A Morphological and behavioral study of demyelination and remyelination in the cuprizone model: Insights into APLNR and NG2+ cell dynamics. Int J Mol Sci, 2024, 25(23):13011. doi: 10.3390/ijms252313011.
- Paxinos G, Franklin K. The mouse brain in stereotaxic co-ordinates. 2nd ed. Academic Press. Cambridge, MA, USA, 2001, 55–63.
- Bradford BM, Walmsley-Rowe L, Reynolds J, et al. Cell adhesion molecule CD44 is dispensable for reactive astrocyte activation during prion disease. Sci Rep, 2024, 14(1):13749. doi: 10.1038/s41598-024-63464-3.
- Kanaan A, Farahani R, Douglas RM, et al. Effect of chronic continuous or intermittent hypoxia and reoxygenation on cerebral capillary density and myelination. Am J Physiol Regul Integr Comp Physiol, 2006, 290(4):R1105-14. doi: 10.1152/ajpregu.00535.2005.